The meeting is a blend of basic science with translational and clinical knowledge with the goal to improve heart failure treatment.
The meeting will analyze the centrality of RNA regulation in biological processes and human disease
The meeting will consist of three plenary sessions, covering all major types of specimens. It will be hosted by International Society for Biological and Environmental Repositories (ISBER) in collaboration with IBBL (Integrated BioBank of Luxembourg).
This event aims to inform about the opportunities for companies and academia under the MSCA ITN scheme, provide guidance on grant writing and preparation and help you get in contact with local scientists and companies that are interested in scientific exchange and innovation.
Cardiolinc partner Biogazelle and Bio-Rad offer a webinar with an overview of the technology, combined with several fields of applications and use cases, focusing on the analysis of liquid biopsies. Additionally, the speakers will provide a framework for good experimental practice, including guidelines for assay design, data analysis, and proper reporting standards.
The Cardiolinc Meeting 2017 will also be during the congress on August 27.
Useful links from the ESC:
Synthesising state-of-the-art insights that span across next-generation sequencing, functional genomics and ncRNA manipulation, this meeting aims to broaden your understanding of the mechanisms behind ncRNA’s regulation of cellular pathways.
The Heart Failure Association (HFA) of the ESC is delighted to invite you to Heart Failure 2017 and the 4th World Congress on Acute Heart Failure. From the 29 April to 2 May, join the Global Heart Failure community in Paris for four days.
The course, in collaboration with Fujifilm VisualSonics, will concentrate on the latest advances in cardiovascular ultrasound imaging, with a strong focus on translational studies. It is expected to foster the collaboration with researchers and clinicians using US imaging for cardiovascular studies and critically discuss the advantages and limitations of US imaging of the cardiovascular system in translational medicine.